153 related articles for article (PubMed ID: 22243289)
1. Review of cytology and histopathology as part of the NHS Cervical Screening Programme audit of invasive cervical cancers.
Castanon A; Ferryman S; Patnick J; Sasieni P
Cytopathology; 2012 Feb; 23(1):13-22. PubMed ID: 22243289
[TBL] [Abstract][Full Text] [Related]
2. Invasive cervical cancer audit: why cancers developed in a high-risk population with an organised screening programme.
Herbert A; Anshu ; Culora G; Dunsmore H; Gupta SS; Holdsworth G; Kubba AA; McLean E; Sim J; Raju KS
BJOG; 2010 May; 117(6):736-45. PubMed ID: 20184570
[TBL] [Abstract][Full Text] [Related]
3. The clinical effectiveness and cost-effectiveness of primary human papillomavirus cervical screening in England: extended follow-up of the ARTISTIC randomised trial cohort through three screening rounds.
C Kitchener H; Canfell K; Gilham C; Sargent A; Roberts C; Desai M; Peto J
Health Technol Assess; 2014 Apr; 18(23):1-196. PubMed ID: 24762804
[TBL] [Abstract][Full Text] [Related]
4. MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial.
Kitchener HC; Blanks R; Cubie H; Desai M; Dunn G; Legood R; Gray A; Sadique Z; Moss S;
Health Technol Assess; 2011 Jan; 15(3):iii-iv, ix-xi, 1-170. PubMed ID: 21266159
[TBL] [Abstract][Full Text] [Related]
5. Reasons for truly negative cytology reports preceding the diagnoses of invasive cervical cancer-Results of a false-negative cytology audit in Polish Cervical Cancer Screening Programme.
Macios A; Komerska K; Nowakowski A
Cancer Med; 2023 Jun; 12(12):13800-13810. PubMed ID: 37211978
[TBL] [Abstract][Full Text] [Related]
6. Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.
Wright TC; Stoler MH; Aslam S; Behrens CM
Am J Clin Pathol; 2016 Sep; 146(3):391-8. PubMed ID: 27543984
[TBL] [Abstract][Full Text] [Related]
7. The use of screening episodes linked to CIN3 and invasive cancer registrations to study outcomes from the NHS Cervical Screening Programme.
Blanks RG; Moss SM; Coleman DA; Addou S; Swerdlow AJ
Cytopathology; 2009 Jun; 20(3):154-60. PubMed ID: 19207309
[TBL] [Abstract][Full Text] [Related]
8. Accuracy of reading liquid based cytology slides using the ThinPrep Imager compared with conventional cytology: prospective study.
Davey E; d'Assuncao J; Irwig L; Macaskill P; Chan SF; Richards A; Farnsworth A
BMJ; 2007 Jul; 335(7609):31. PubMed ID: 17604301
[TBL] [Abstract][Full Text] [Related]
9. Review of negative and low-grade cervical smears in women with invasive cervical cancer after the first 3 years of the national cervical screening programme in Slovenia.
Repše-Fokter A; Pogačnik A; Snoj V; Primic-Žakelj M; Fležar MS
Cytopathology; 2012 Feb; 23(1):23-9. PubMed ID: 20964743
[TBL] [Abstract][Full Text] [Related]
10. HPV testing compared with routine cytology in cervical screening: long-term follow-up of ARTISTIC RCT.
Gilham C; Sargent A; Kitchener HC; Peto J
Health Technol Assess; 2019 Jun; 23(28):1-44. PubMed ID: 31219027
[TBL] [Abstract][Full Text] [Related]
11. Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study.
Castle PE; Stoler MH; Wright TC; Sharma A; Wright TL; Behrens CM
Lancet Oncol; 2011 Sep; 12(9):880-90. PubMed ID: 21865084
[TBL] [Abstract][Full Text] [Related]
12. Morphologic characteristics of p16INK4a-positive cells in cervical cytology samples.
Trunk MJ; Dallenbach-Hellweg G; Ridder R; Petry KU; Ikenberg H; Schneider V; von Knebel Doeberitz M
Acta Cytol; 2004; 48(6):771-82. PubMed ID: 15581161
[TBL] [Abstract][Full Text] [Related]
13. Cervical glandular neoplasia referrals and the diagnosis of adenocarcinoma in situ: Correlating cytology, colposcopy findings, and clinical outcomes.
Nikolopoulos M; Athanasias P; Godfrey MAL; Nikolopoulos K; Maheshwari MK
Cytopathology; 2021 Nov; 32(6):751-757. PubMed ID: 34181788
[TBL] [Abstract][Full Text] [Related]
14. Four and a half year follow up of women with dyskaryotic cervical smears.
Fletcher A; Metaxas N; Grubb C; Chamberlain J
BMJ; 1990 Sep; 301(6753):641-4. PubMed ID: 2224218
[TBL] [Abstract][Full Text] [Related]
15. The borderline cervical smear: colposcopic and biopsy outcome.
al-Nafussi A; Rebello G; al-Yusif R; McGoogan E
J Clin Pathol; 2000 Jun; 53(6):439-44. PubMed ID: 10911801
[TBL] [Abstract][Full Text] [Related]
16. The artificial intelligence-assisted cytology diagnostic system in large-scale cervical cancer screening: A population-based cohort study of 0.7 million women.
Bao H; Sun X; Zhang Y; Pang B; Li H; Zhou L; Wu F; Cao D; Wang J; Turic B; Wang L
Cancer Med; 2020 Sep; 9(18):6896-6906. PubMed ID: 32697872
[TBL] [Abstract][Full Text] [Related]
17. Comparison of cytology and histology results in English cervical screening laboratories before and after liquid-based cytology conversion: do the data provide evidence for a single category of high-grade dyskaryosis?
Blanks RG; Kelly RS
Cytopathology; 2010 Dec; 21(6):368-73. PubMed ID: 20955376
[TBL] [Abstract][Full Text] [Related]
18. Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review.
Lim AW; Landy R; Castanon A; Hollingworth A; Hamilton W; Dudding N; Sasieni P
Br J Gen Pract; 2016 Dec; 66(653):e871-e879. PubMed ID: 27777232
[TBL] [Abstract][Full Text] [Related]
19. Nationwide Rereview of Normal Cervical Cytologies before High-Grade Cervical Lesions or before Invasive Cervical Cancer.
Edvardsson H; Wang J; Andrae B; Sparén P; Strander B; Dillner J
Acta Cytol; 2021; 65(5):377-384. PubMed ID: 34077926
[TBL] [Abstract][Full Text] [Related]
20. Cervical cytology and the diagnosis of cervical cancer in older women.
Landy R; Castanon A; Dudding N; Lim AW; Hollingworth A; Hamilton W; Sasieni PD
J Med Screen; 2015 Dec; 22(4):207-12. PubMed ID: 26346038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
